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Synthesis of Precursors 5 and 6
Scheme S1. Synthesis of precursor 5. Reagents and conditions: (a) NaN 3 
3-Azidopropan-1-amine (S2). [1]
To a solution of 3-bromopropan-1-amine hydrobromide (S1, 14.2 g, 64.9 mmol) in H 2 O (45 mL) was added dropwise a solution of sodium azide (14.1 g, 217 mmol) in H 2 O. The reaction mixture was heated at reflux for 16 h and concentrated to one-third its original volume under reduced pressure. To the ice-cooled residue was added Et 2 O (225 mL), followed by KOH pellets (18.0 g, 321 mmol) portionwise keeping the temperature below 10 °C. The organic layer was separated, and the aqueous layer was extracted with Et 2 O (2 × 135 mL). The combined organic layers were dried over K 2 CO 3 and concentrated under reduced pressure and in vacuo to give S2 as a pale yellow oil (5.73 g, 88%) . IR ν max /cm -1 3368, 3294, 2938, 2871, 2089, 1596, 1458, 1256, 846. 1 
H NMR
(300 MHz, CDCl 3 ) δ 1.22 (s, 2H, NH 2 ), 1.67-1.77 (m, 2H, CH 2 CH 2 CH 2 ), 2.79 (t, 2H, J 6.6, NH 2 CH 2 ), 3.37 (t, 2H, J 6.6, CH 2 N 3 ) . 13 C NMR (75 MHz, CDCl 3 ) δ 32.2, 39.0, 48.8. MS (APCI) m/z 100.5 ([M+H] + , 100%). The spectroscopic data were in agreement with those in the literature. [1] 
(S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoic acid (S4). [2]
To a solution of L-tert-leucine (S3, 4.58 g, 34.9 mmol) and NaOH (1.54 g, 38.5 mmol) in tBuOH/H 2 O (50 mL/50 mL) was added di-tert-butyl dicarbonate (8.40 g, 38.5 mmol) .
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(2S,3S)-Diethyl 2,3-dihydroxysuccinate (S7). [3] To a solution of D-tartaric acid (S6, 29.0 g, 0.193 mol) in anhydrous EtOH (290 mL) was added dropwise thionyl chloride (31.2 mL, 0.430 mol). The mixture was stirred at room temperature for 48 h and concentrated under reduced pressure. The residue was diluted with DCM (60 mL) and washed with saturated NaHCO 3 (40 mL). The aqueous layer was back-extracted with DCM (2 × 20 mL). The combined organic phases were washed with brine (40 mL), dried over Na 2 SO 4 and concentrated under reduced pressure to give S7 as a colourless oil (39.8 g, 100%) .
[α] D 20 -26.0 (c 0.2, H 2 O) (lit. [3] [α] D 20 -25.0 (c 0.2, H 2 O)). IR ν max /cm -1 3473, 2984, 2941, 2911, 2879, 1732, 1634, 1470, 1448, 1391, 1370, 1223, 1126, 1083, 1016, 862, 730, 708, 596 with those in the literature. [3] (2R,3R) Diethyl 2-acetoxy-3-bromosuccinate (S8). [4] To ice-cooled S7 (20.0 g, 97.0 mmol) was added dropwise a solution of HBr in AcOH (33%, 60.0 mL) over 30 min. The mixture was allowed to warm to room temperature, stirred for 16 h and poured onto crushed ice (85 g) which was allowed to melt. The aqueous solution was extracted with Et 2 O (4 × 100 mL). 1, 20.4, 43.9, 62.3, 63.0, 72.8, 165.7, 166.3, 169.4 (2S,3S)-Diethyl oxirane-2,3-dicarboxylate (S10).
EtONa Method: [4a] To anhydrous EtOH (3 mL) was added Na (100 
(R)-N-((S)-1-((3-Azidopropyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)-2-((S)-2,2-
dimethyl-5-oxo-1,3-dioxolan-4-yl)-4-methylpentanamide (7).
To a solution of compound 6 (136 mg, 0.591 mmol), EDC·HCl (124 mg, 0.647 mmol), IR ν max /cm -1 3319, 2956, 2874, 2095, 1784, 1641, 1531, 1464, 1375, 1259, 1125, 984, 895, 756, 666, 627, 550 1, 25.7, 25.8, 26.7, 28.9, 34.6, 36.8, 37.2, 47.2, 49.2, 60.6, 74.7, 111.0, 170.6, 170.8, 171.9 
(2S,3R)-3-(((S)-1-((3-Azidopropyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamoyl)-2-hydroxy-5-methylhexanoic acid (8).
Compound 8 6.74, N 14.63; Found: C 37.29, H 6.41, N 14 .47.
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1 H NMR Analysis for Recrystallization of Azide-Capped Marimastat 7
Figure S1. 1 H NMR spectra of 7 after purification by flash column chromatography (a) and recrystallization (b) compared to the 1 H NMR spectrum of the mother liquor concentrate (c) in CDCl 3 . S:
nondeuterated solvent residual peaks. 
RP-HPLC Purification of the Cyclam-Marimastat Conjugate 12
Removal of the Boc groups from 11 was carried out in a mixture of TFA/DCM/H 2 O (90:5:5). The crude products were initially purified by RP-HPLC using gradient 5% to 25% CH 3 CN over 45 minutes, which gave excellent separation of a truncated cyclammarimastat conjugate with loss of the succinate-derived moiety (S13, Figure S2(a) ) from a mixture of the desired trifluoroacetate 12 and unidentified impurities. The complete separation of this mixture was ultimately achieved by eluting the column with 5% CH 3 CN for 15 minutes prior to applying the aforementioned gradient ( Figure S2(b) ). relative to a non-treated control and listed in Table S1 . Table S1 . Cytotoxicity of the marimastat derivatives 7-9 and 11-14 against THP1. 
Compound
